Learn about homologous recombination deficiency and its genomic effects. An interactive augmented reality app for healthcare professionals.
AstraZeneca and MSD collaborate within the oncology space and both companies have
endorsed the scientific content of this application. The sole proprietor of this application is AstraZeneca.
This app is not a medical device. For healthcare professional use only.
Date of preparation: March 2021
AstraZeneca and MSD collaborate within the oncology space and both companies have
endorsed the scientific content of this application. The sole proprietor of this application is AstraZeneca.
This app is not a medical device. For healthcare professional use only.
Date of preparation: March 2021
Show More
